Drug Targeting of Inflammatory Bowel Diseases by Biomolecules
Inflammatory bowel disease (IBD) is a group of disabling, destructive and incurable immune-mediated inflammatory diseases comprising Crohn’s disease (CD) and ulcerative colitis (UC), disorders that are highly prevalent worldwide and demand a large investment in healthcare. A persistent inflammatory...
Main Authors: | Joana Costa Antunes, Catarina Leal Seabra, Joana Margarida Domingues, Marta Oliveira Teixeira, Cláudia Nunes, Sofia Antunes Costa-Lima, Natália Cândido Homem, Salette Reis, Maria Teresa Pessoa Amorim, Helena Prado Felgueiras |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/8/2035 |
Similar Items
-
The current standard of care of inflammatory bowel disease
by: J Wright
Published: (2024-03-01) -
Homeostasis and Dysbiosis of the Intestinal Microbiota: Comparing Hallmarks of a Healthy State with Changes in Inflammatory Bowel Disease
by: Jasminka Talapko, et al.
Published: (2022-12-01) -
Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01) -
The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
by: Laila Aldars-García, et al.
Published: (2021-03-01) -
Sources of Bias in Common Diagnosis of Chronic Inflammatory Bowel Diseases
by: O. A. Svatkova, et al.
Published: (2020-12-01)